In January 2021, the below number of individuals have been recruited in Swedegene. DNA and clinical data collection for these are completed.

ADR type	Number
Angioedema	530
Anaphylaxis	134
Urticaria	185
Other allergic reactions	112
Cough related to ACE-inhibitors	150
Osteonecrosis and atypical fractures due to bisphosphonates	122
Phototoxic reactions (mainly due to topical NSAIDs)	51
Blood cell dyscrasia (agranulocytosis, thrombocytopenia and anemia) to non-cytostatic drugs	276
Metabolic reactions from neuroleptics and antidepressants (mainly weight gain)	53
Hyponatremia/SIADH due to antidepressants and antiepileptics	38
CNS toxicity and neuropsychiatric reactions from antiviral therapy and antibiotics	93
Stevens-Johnson syndrome/Toxic epidermal necrolysis	64
Tendon-rupture from flouroquinolones	27
Liver toxicity	462
Rhabdomyolysis related to statins/fibrates	52
Torsade de Pointes/QT-prolongation	23
Narcolepsy associated with Pandemrix	83
Pancreatitis	90
Alopecia	28
Bleedings from new oral anticoagulants (NOACs)	101
Lack of efficacy of NOACs	31
Pneumonitis	23
Renal toxicity	73
Controls	580
Total number of cases	3341

ACE = angiotensin converting enzyme; NSAID = non-steroidal anti-inflammatory drug; NOAC=non-vitamin K oral anticoagulant drug.

Note that the number of cases for a particular ADR may be greater than the total number of cases as some individuals have experienced multiple ADRs concomitantly.